DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: From Qualitative to Quantitative AOP: A Case Study of Neurodegeneration

Abstract

Adverse outcome pathways (AOPs) include a sequence of events that connect a molecular-level initiating event with an adverse outcome at the cellular level for human health endpoints, or at the population level for ecological endpoints. When there is enough quantitative understanding of the relationships between key events in an AOP, a mathematical model may be developed to connect key events in a quantitative AOP (qAOP). Ideally, a qAOP will reduce the time and resources spent for chemical toxicity testing and risk assessment and enable the extrapolation of data collected at the molecular-level by in vitro assays, for example, to predict whether an adverse outcome may occur. Here, we review AOPs in the AOPWiki, an AOP repository, to determine best practices that would facilitate conversion from AOP to qAOP. Then, focusing on a particular case study, acetylcholinesterase inhibition leading to neurodegeneration, we describe specific methods and challenges. Examples of challenges include the availability and collection of quantitative data amenable to model development, the lack of studies that measure multiple key events, and model accessibility or transferability across platforms. We conclude with recommendations for improving key event and key event relationship descriptions in the AOPWiki that facilitate the transition of qualitative AOPsmore » to qAOPs.« less

Authors:
; ;
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1860282
Resource Type:
Published Article
Journal Name:
Frontiers in Toxicology
Additional Journal Information:
Journal Name: Frontiers in Toxicology Journal Volume: 4; Journal ID: ISSN 2673-3080
Publisher:
Frontiers Media SA
Country of Publication:
Switzerland
Language:
English

Citation Formats

Sinitsyn, Dennis, Garcia-Reyero, Natàlia, and Watanabe, Karen H. From Qualitative to Quantitative AOP: A Case Study of Neurodegeneration. Switzerland: N. p., 2022. Web. doi:10.3389/ftox.2022.838729.
Sinitsyn, Dennis, Garcia-Reyero, Natàlia, & Watanabe, Karen H. From Qualitative to Quantitative AOP: A Case Study of Neurodegeneration. Switzerland. https://doi.org/10.3389/ftox.2022.838729
Sinitsyn, Dennis, Garcia-Reyero, Natàlia, and Watanabe, Karen H. Wed . "From Qualitative to Quantitative AOP: A Case Study of Neurodegeneration". Switzerland. https://doi.org/10.3389/ftox.2022.838729.
@article{osti_1860282,
title = {From Qualitative to Quantitative AOP: A Case Study of Neurodegeneration},
author = {Sinitsyn, Dennis and Garcia-Reyero, Natàlia and Watanabe, Karen H.},
abstractNote = {Adverse outcome pathways (AOPs) include a sequence of events that connect a molecular-level initiating event with an adverse outcome at the cellular level for human health endpoints, or at the population level for ecological endpoints. When there is enough quantitative understanding of the relationships between key events in an AOP, a mathematical model may be developed to connect key events in a quantitative AOP (qAOP). Ideally, a qAOP will reduce the time and resources spent for chemical toxicity testing and risk assessment and enable the extrapolation of data collected at the molecular-level by in vitro assays, for example, to predict whether an adverse outcome may occur. Here, we review AOPs in the AOPWiki, an AOP repository, to determine best practices that would facilitate conversion from AOP to qAOP. Then, focusing on a particular case study, acetylcholinesterase inhibition leading to neurodegeneration, we describe specific methods and challenges. Examples of challenges include the availability and collection of quantitative data amenable to model development, the lack of studies that measure multiple key events, and model accessibility or transferability across platforms. We conclude with recommendations for improving key event and key event relationship descriptions in the AOPWiki that facilitate the transition of qualitative AOPs to qAOPs.},
doi = {10.3389/ftox.2022.838729},
journal = {Frontiers in Toxicology},
number = ,
volume = 4,
place = {Switzerland},
year = {Wed Mar 30 00:00:00 EDT 2022},
month = {Wed Mar 30 00:00:00 EDT 2022}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.3389/ftox.2022.838729

Save / Share:

Works referenced in this record:

Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment
journal, September 2001


Statistical Issues in Toxicokinetic Modeling: A Bayesian Perspective
journal, October 2000

  • Bernillon, Pascale; Bois, Frederic Y.
  • Environmental Health Perspectives, Vol. 108
  • DOI: 10.2307/3454322

Towards a qAOP framework for predictive toxicology - Linking data to decisions
journal, February 2022


A Computational Model of the Rainbow Trout Hypothalamus-Pituitary-Ovary-Liver Axis
journal, April 2016


Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions
journal, December 1996

  • Gelman, Andrew; Bois, Frederic; Jiang, Jiming
  • Journal of the American Statistical Association, Vol. 91, Issue 436
  • DOI: 10.1080/01621459.1996.10476708

Quantitative MRI predicts status epilepticus-induced hippocampal injury in the lithium–pilocarpine rat model
journal, February 2010


A Computational Model of the Cholinergic Modulation of CA1 Pyramidal Cell Activity
journal, September 2020

  • Mergenthal, Adam; Bouteiller, Jean-Marie C.; Yu, Gene J.
  • Frontiers in Computational Neuroscience, Vol. 14
  • DOI: 10.3389/fncom.2020.00075

Predicting the Probability that a Chemical Causes Steatosis Using Adverse Outcome Pathway Bayesian Networks (AOPBNs)
journal, November 2019

  • Burgoon, Lyle D.; Angrish, Michelle; Garcia‐Reyero, Natalia
  • Risk Analysis, Vol. 40, Issue 3
  • DOI: 10.1111/risa.13423

Species extrapolation for the 21st century
journal, November 2010

  • Celander, Malin C.; Goldstone, Jared V.; Denslow, Nancy D.
  • Environmental Toxicology and Chemistry, Vol. 30, Issue 1
  • DOI: 10.1002/etc.382

A Cross-species Quantitative Adverse Outcome Pathway for Activation of the Aryl Hydrocarbon Receptor Leading to Early Life Stage Mortality in Birds and Fishes
journal, June 2018

  • Doering, Jon A.; Wiseman, Steve; Giesy, John P.
  • Environmental Science & Technology, Vol. 52, Issue 13
  • DOI: 10.1021/acs.est.8b01438

Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations
journal, January 1990


Quantification of an Adverse Outcome Pathway Network by Bayesian Regression and Bayesian Network Modeling
journal, October 2020

  • Moe, S. Jannicke; Wolf, Raoul; Xie, Li
  • Integrated Environmental Assessment and Management, Vol. 17, Issue 1
  • DOI: 10.1002/ieam.4348

Quantitative adverse outcome pathway (qAOP) models for toxicity prediction
journal, May 2020


Modeling and simulation of organophosphate-induced neurotoxicity: Prediction and validation by experimental studies
journal, May 2016


BioModels—15 years of sharing computational models in life science
journal, November 2019

  • Malik-Sheriff, Rahuman S.; Glont, Mihai; Nguyen, Tung V. N.
  • Nucleic Acids Research
  • DOI: 10.1093/nar/gkz1055

Quantitative Adverse Outcome Pathways and Their Application to Predictive Toxicology
journal, April 2017

  • Conolly, Rory B.; Ankley, Gerald T.; Cheng, WanYun
  • Environmental Science & Technology, Vol. 51, Issue 8
  • DOI: 10.1021/acs.est.6b06230

Quantitative Response-Response Relationships Linking Aromatase Inhibition to Decreased Fecundity are Conserved Across Three Fishes with Asynchronous Oocyte Development
journal, August 2019

  • Doering, Jon A.; Villeneuve, Daniel L.; Poole, Shane T.
  • Environmental Science & Technology, Vol. 53, Issue 17
  • DOI: 10.1021/acs.est.9b02606

The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models
journal, March 2003


Adverse outcome pathways: opportunities, limitations and open questions
journal, October 2017


Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: Influence of septal cholinoceptive cells
journal, May 1992


Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats
journal, September 1999


Kinetics of M1 muscarinic receptor and G protein signaling to phospholipase C in living cells
journal, January 2010

  • Falkenburger, Björn H.; Jensen, Jill B.; Hille, Bertil
  • Journal of General Physiology, Vol. 135, Issue 2
  • DOI: 10.1085/jgp.200910344

Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman
journal, June 2021


Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence
journal, August 2015

  • Becker, Richard A.; Ankley, Gerald T.; Edwards, Stephen W.
  • Regulatory Toxicology and Pharmacology, Vol. 72, Issue 3
  • DOI: 10.1016/j.yrtph.2015.04.004

Vulnerability of CA1 neurons to glutamate is developmentally regulated
journal, December 1996


Quantitative Adverse Outcome Pathway Analysis of Hatching in Zebrafish with CuO Nanoparticles
journal, September 2015

  • Muller, Erik B.; Lin, Sijie; Nisbet, Roger M.
  • Environmental Science & Technology, Vol. 49, Issue 19
  • DOI: 10.1021/acs.est.5b01837

Biological basis for extrapolation across mammalian species
journal, September 1986

  • Davidson, I. W. F.; Parker, J. C.; Beliles, R. P.
  • Regulatory Toxicology and Pharmacology, Vol. 6, Issue 3
  • DOI: 10.1016/0273-2300(86)90014-0

Application of three approaches for quantitative AOP development to renal toxicity
journal, August 2019


Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment
journal, March 2010

  • Ankley, Gerald T.; Bennett, Richard S.; Erickson, Russell J.
  • Environmental Toxicology and Chemistry, Vol. 29, Issue 3
  • DOI: 10.1002/etc.34

Toward good in vitro reporting standards
journal, January 2019


Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment
journal, August 2019

  • Perkins, Edward J.; Ashauer, Roman; Burgoon, Lyle
  • Environmental Toxicology and Chemistry, Vol. 38, Issue 9
  • DOI: 10.1002/etc.4505

Robust Likelihood‐Based Approach for Automated Optimization and Uncertainty Analysis of Toxicokinetic‐Toxicodynamic Models
journal, October 2020

  • Jager, Tjalling
  • Integrated Environmental Assessment and Management, Vol. 17, Issue 2
  • DOI: 10.1002/ieam.4333

A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists
journal, April 2015

  • Miller, Steven L.; Aroniadou-Anderjaska, Vassiliki; Figueiredo, Taiza H.
  • Toxicology and Applied Pharmacology, Vol. 284, Issue 2
  • DOI: 10.1016/j.taap.2015.02.008

Animal Models That Best Reproduce the Clinical Manifestations of Human Intoxication with Organophosphorus Compounds
journal, June 2014

  • Pereira, Edna F. R.; Aracava, Yasco; DeTolla, Louis J.
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 350, Issue 2
  • DOI: 10.1124/jpet.114.214932